Leveraging Big Data and AI to Personalize Pediatric Orthopedic Care
Ata Kiapour is an Assistant Professor of Orthopaedic Surgery at Harvard Medical School and the Director of the Musculoskeletal Informatics Group (MIG) in Department of Orthopaedic Surgery and Sports Medicine at Boston Children’s Hospital. Dr. Kiapour’s research is focused on developing new methods for analyzing clinical data (e.g. imaging) to better understand the etiology and mechanisms of musculoskeletal diseases and to develop new tools for injury prediction and to facilitate clinical decision-making (e.g. treatment choice). His approaches have been applied in several domains, including studying joint morphogenesis and its implications in injury risk and treatment outcomes, development of new imaging biomarkers to track tissue healing and response to treatment, and development of simulation tools for surgical planning. Dr. Kiapour founded the Musculoskeletal Informatics Group (MIG) in 2021 with the mission of developing novel analytical tools to facilitate the use of “big” clinical data to: 1) improve our understanding of musculoskeletal diseases among pediatrics and young adults, 2) optimize clinical care for such diseases, and 3) improve the quality of life of patients with such conditions.
Date and Time
Location
Hosts
Registration
- Date: 26 Apr 2022
- Time: 06:00 PM to 07:00 PM
- All times are (GMT-05:00) US/Eastern
-
Add Event to Calendar
- Boston, Massachusetts
- United States
- Starts 02 April 2022 12:47 PM
- Ends 26 April 2022 06:30 PM
- All times are (GMT-05:00) US/Eastern
- No Admission Charge
Speakers
Leveraging Big Data and AI to Personalize Pediatric Orthopedic Care
Biography:
Ata Kiapour is an Assistant Professor of Orthopaedic Surgery at Harvard Medical School and the Director of the Musculoskeletal Informatics Group (MIG) in Department of Orthopaedic Surgery and Sports Medicine at Boston Children’s Hospital. Dr. Kiapour’s research is focused on developing new methods for analyzing clinical data (e.g. imaging) to better understand the etiology and mechanisms of musculoskeletal diseases and to develop new tools for injury prediction and to facilitate clinical decision-making (e.g. treatment choice). His approaches have been applied in several domains, including studying joint morphogenesis and its implications in injury risk and treatment outcomes, development of new imaging biomarkers to track tissue healing and response to treatment, and development of simulation tools for surgical planning. Dr. Kiapour founded the Musculoskeletal Informatics Group (MIG) in 2021 with the mission of developing novel analytical tools to facilitate the use of “big” clinical data to: 1) improve our understanding of musculoskeletal diseases among pediatrics and young adults, 2) optimize clinical care for such diseases, and 3) improve the quality of life of patients with such conditions.